Cargando…

Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling

While cancer-associated fibroblasts (CAFs) in the tumour microenvironment may play important roles in bladder cancer (BCa) progression, their impacts on BCa chemoresistance remain unclear. Using human BCa samples, we found that tumour tissues possessed more CAFs than did adjacent normal tissues. Bot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Xingbo, Xiong, Wei, Zeng, Xiting, Qi, Lin, Cai, Yi, Mo, Miao, Jiang, Huichuan, Zhu, Bisong, Chen, Zhi, Li, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510780/ https://www.ncbi.nlm.nih.gov/pubmed/31076571 http://dx.doi.org/10.1038/s41419-019-1581-6

Ejemplares similares

Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision‐making processes
por: Long, Xingbo, et al.
Publicado: (2020)

Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines
por: Kim, Sung Han, et al.
Publicado: (2016)

The role of cancer-associated fibroblasts in bladder cancer progression
por: Huang, Long, et al.
Publicado: (2023)

Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy
por: Chen, Jinbo, et al.
Publicado: (2016)

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin
por: Bansal, Nisha, et al.
Publicado: (2012)

MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
por: Zhang, Xin, et al.
Publicado: (2015)

Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca(2+) signaling in SKOV3 cells
por: Xu, Lu, et al.
Publicado: (2018)

Critical role of SOX2–IGF2 signaling in aggressiveness of bladder cancer
por: Chiu, Yu-Fan, et al.
Publicado: (2020)

Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells
por: Du, Juan, et al.
Publicado: (2017)

DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups
por: Tian, Zijian, et al.
Publicado: (2020)

Interaction between IGF-IR and ER Induced by E2 and IGF-I
por: Yu, Zhenghong, et al.
Publicado: (2013)

Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance
por: Leisching, Gina, et al.
Publicado: (2015)

ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion
por: Wu, Longxiang, et al.
Publicado: (2019)

The effect of cisplatin in 5637 bladder cancer cell line
por: Pinto-Leite, Rosário, et al.
Publicado: (2010)

Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance
por: Lee, Min Young, et al.
Publicado: (2018)

Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
por: Shi, Zhen-duo, et al.
Publicado: (2022)

CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells
por: Mo, Miao, et al.
Publicado: (2015)

Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia
por: Hirakawa, Toshiki, et al.
Publicado: (2016)

Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER(+) breast cancer
por: Deng, Jing, et al.
Publicado: (2013)

LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis
por: Tang, Congyi, et al.
Publicado: (2020)

Nicotine increases the resistance of lung cancer cells to cisplatin through enhancing Bcl-2 stability
por: Nishioka, T, et al.
Publicado: (2014)

FOXO1 inactivation induces cisplatin resistance in bladder cancer
por: Ide, Hiroki, et al.
Publicado: (2020)

Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS
por: Pan, Xiaobo, et al.
Publicado: (2022)

OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells
por: Wang, Dailian, et al.
Publicado: (2018)

Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells
por: Miyake, H, et al.
Publicado: (1999)

TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer
por: Lin, Zhi-Rui, et al.
Publicado: (2018)

Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells
por: KUNZE, DOREEN, et al.
Publicado: (2012)

Fibroblast growth factor 21 is related to cisplatin resistance in ovarian cancer
por: Zhong, Qian, et al.
Publicado: (2022)

ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells
por: SHI, SHAOMIN, et al.
Publicado: (2016)

ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins
por: Alcon, Clara, et al.
Publicado: (2021)

Discoidin Domain Receptor 1 functionally interacts with the IGF-I system in bladder cancer
por: Buraschi, Simone, et al.
Publicado: (2020)

Effects of increased Kindlin-2 expression in bladder cancer stromal fibroblasts
por: Wu, Jitao, et al.
Publicado: (2017)

Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
por: Narayan, Vivek, et al.
Publicado: (2016)

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
por: Xylinas, Evanguelos, et al.
Publicado: (2016)

Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer
por: Kashiwagi, Eiji, et al.
Publicado: (2016)

Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer
por: Rajendran, Ganeshkumar, et al.
Publicado: (2021)

FOXC1 Binds Enhancers and Promotes Cisplatin Resistance in Bladder Cancer
por: Lu, Yi-Tsung, et al.
Publicado: (2022)

Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment
por: Yang, Chen, et al.
Publicado: (2023)

Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin
por: Buraschi, Simone, et al.
Publicado: (2016)

Role of IGF-1 pathway in lung fibroblast activation
por: Hung, Chi F, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_97gchujh5iptdmb6o1pt1pccu0